Immunogenetics and Immunologic Mechanisms of Rejection

The major histocompatibility complex (MHC) is a group of genes found in a region on the short arm of the sixth chromosome in man (Fig. 2.1).1 This region codes for histocompatibility antigens that are known to be the strongest barriers to transplantation of organs from one human individual to another2; these antigens elicit strong immune responses when they are not matched. Experience in kidney allograft transplantation has demonstrated that matching for these antigens within families and between unrelated individuals (as in cadaveric kidney transplantation) significantly reduces the strength of the immune response and leads to superior graft survival.3 This is also the case in bone marrow transplantation, wherein successful engraftment relies on both the absence of rejection and the absence of a graft-versus-host reaction. To achieve this, the histocompatibility antigen discrepancy must be minimal when donor cells scrutinize the recipient and when recipient cells scrutinize donor cells.4 All vertebrate animals that have been studied, including rodents, dogs, lower primates, and swine, have a major histocompatibility complex. In man, the glycoprotein gene products of the major histocompatibility complex are known as human leukocyte antigens, or HLA.

[1]  N. Rose,et al.  Manual of clinical immunology , 1976 .

[2]  B. Hall,et al.  The cellular basis of allograft rejection in vivo. III. Restoration of first-set rejection of heart grafts by T helper cells in irradiated rats. , 1983, Transplantation.

[3]  H. Perkins,et al.  Flow cytometry analysis: A high technology cross-match technique facilitating transplantation , 1983 .

[4]  C. F. Anderson Kidney transplant rejection : diagnosis and treatment , 1986 .

[5]  G. Nossal The Basic Components of the Immune System , 1987 .

[6]  A. Zachary,et al.  Autolymphocytotoxins in Cardiac Transplantation: Serology, Significance, and Association with HLA-A1 and HLA-A3 , 1989 .

[7]  D. Wakelin,et al.  The Immune Response , 1983 .

[8]  P. M. Chisholm,et al.  USE OF MONOCLONAL ANTIBODIES TO QUANTITATE T LYMPHOCYTE SUBPOPULATIONS IN HUMAN CARDIAC ALLOGRAFTS , 1984, Transplantation.

[9]  M. Baur,et al.  Histocompatibility Testing 1984 , 1985, Springer Berlin Heidelberg.

[10]  J. Hiatt,et al.  Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. , 1989, Transplantation.

[11]  B. DuPont Nomenclature for factors of the HLA system, 1987. Decisions of the Nomenclature Committee on Leukocyte Antigens, which met in New York on November 21-23, 1987. , 1989, Human immunology.

[12]  J. Najarian,et al.  Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches. , 1987, Transplantation proceedings.

[13]  O. Fjeldborg,et al.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. , 1966, Lancet.

[14]  K. Tung,et al.  ABO blood group incompatibility in human renal homotransplantation. , 1969, American journal of clinical pathology.

[15]  J. Bidwell DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens. , 1988, Immunology today.

[16]  L. Sandu Letter: Corticosteroids in Landry-Guillain-Barré-Strohl syndrome. , 1974, Lancet.

[17]  A. Pavie,et al.  Current problems in cardiac transplantation. , 1989, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  M. A. Head,et al.  5.5-02 Cytotoxic flow crossmateches , 1989 .

[19]  J. Chapman,et al.  IMMUNOGLOBULIN CLASS AND SPECIFICITY OF ANTIBODIES CAUSING POSITIVE T CELL CROSSMATCHES: RELATIONSHIP TO RENAL TRANSPLANT OUTCOME , 1986, Transplantation.

[20]  A. Khaghani,et al.  Cardiac transplantation at Harefield Hospital. , 1987, Clinical transplants.

[21]  M. R. Mickey,et al.  Low kidney graft survival in Lewis negative patients after regrafting and newer matching schemes for Lewis. , 1987, Transplantation proceedings.

[22]  J. Dausset,et al.  HLA at the Gene Level , 1984 .

[23]  Julia G. Bodmer,et al.  Nomenclature for factors of the HLA system, 1987. , 1988, Tissue antigens.

[24]  M. Goldman,et al.  CLINICAL SIGNIFICANCE OF IN SITU DETECTION OF T LYMPHOCYTE SUBSETS AND MONOCYTE/MACROPHAGE LINEAGES IN HEART ALLOGRAFTS , 1984, Transplantation.

[25]  P. Russell,et al.  Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients. , 1978, Transplantation proceedings.